Roger Perl­mut­ter lures Roy Baynes away from Mer­ck; Now, Voy­ager: Al San­drock be­comes a CEO af­ter break from Bio­gen

→ Pro­fes­sion­al sports teams cy­cle through free agency every year, and core vet­er­ans from cham­pi­onship clubs rou­tine­ly splin­ter off in dif­fer­ent di­rec­tions. In a sim­i­lar vein, Mer­ck in par­tic­u­lar has seen wide­spread turnover with its own nu­cle­us of tal­ent that helped Keytru­da be­come one of the biggest block­busters in the in­dus­try, whether it’s CEO Ken Fra­zier pass­ing the ba­ton to Rob Davis or chief mar­ket­ing of­fi­cer Mike Nal­ly tak­ing the helm at Flag­ship’s Gen­er­ate Bio­med­i­cines. An­oth­er big name at the phar­ma gi­ant, Mer­ck Re­search Lab­o­ra­to­ries CMO Roy Baynes, has de­cid­ed to move on him­self — and he’ll be back with an old team­mate.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER